Ten out of 11 mutual fund houses covered by Nuvama Alternative Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200.
Ten out of 11 mutual fund houses covered by Nuvama Alternative Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200. Ten out of 11 mutual fund houses covered by Nuvama Alternative Quantitative Research have gone overweight on pharma and healthcare, as against their weightage in Nifty 200. Moneycontrol Latest News Read More
English 
हिन्दी